Table 3.
Survival probability at 3 years and 4 years in BCG Danish 1331 and BCG Moscow-I strain groups.
| Variable | Median survival probability at 3 years, %; (95% CI) | Median survival at 4 years, %; (95% CI) | p-Value |
|---|---|---|---|
| RFS | |||
| BCG Danish 1331 | 80.0; (75.6–84.4) | 68.2; (63.8–72.6) | 0.397 |
| BCG Moscow-I | 72.9; (70.9–74.9) | 59.2; (57.2–61.2) | |
| PFS | |||
| BCG Danish 1331 | 96.5; (93.0–100.0) | 86.1; (82.5–89.7) | 0.703 |
| BCG Moscow-I | 97.8; (96.6–99.0) | 79.5; (78.3–80.7) | |
| OS | |||
| BCG Danish 1331 | 94.6; (91.6–97.6) | 88.2; (85.2–91.2) | 0.373 |
| BCG Moscow-I | 88.9; (87.6–90.2) | 83.5; (82.2–94.8) | |
| DSS | |||
| BCG Danish 1331 | 98.2; (96.5–99.9) | 94.9; (93.2–96.6) | 0.554 |
| BCG Moscow-I | 97.6; (96.8–98.4) | 94.0; (96.8–98.4) | |
BCG, bacillus Calmette-Guerin; PFS, progression-free survival; RFS, recurrence-free; OS, overall survival; DSS, disease-specific survival; CI, confidence interval.